Type 1 Invariant Natural Killer T Cells Drive Lung Fibrosis
2024 · American Journal of Respiratory and Critical Care Medicine · 4 citations
https://doi.org/10.1164/rccm.202402-0288le
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
8
Papers
302
Citations
4
h-index
3
i10-index
Emily Calamita is an academic researcher from Imperial College London. The author has contributed to research in topics: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis & Neonatal Respiratory Health Research & Chronic Obstructive Pulmonary Disease (COPD) Research. The author has an h-index of 4, co-authored 7 publications.
ORCID: 0000-0003-4864-9944Click to start Chat